Summary
This guide provides an overview of ICH Q8 compliance, which is a regulatory guideline focusing on pharmaceutical development and the implementation of quality by design (QbD) principles. It outlines the systematic approach necessary for developing and optimizing pharmaceutical formulations and manufacturing processes. The document emphasizes the importance of understanding critical quality attributes (CQAs) and the intended use of products, as well as the role of risk management in ensuring product quality. It discusses the relationship between ICH Q8 and other guidelines, such as ICH Q9 and Q10, and presents the benefits of adopting ICH Q8 compliance, including improved patient-centricity, cost-effectiveness, innovation, and timely market delivery. The guide also details the Quality Target Product Profile (QTPP) and its significance in the development process, along with the identification and management of CQAs. Overall, it serves as a comprehensive resource for pharmaceutical organizations aiming to enhance their quality management practices.
